Showing results (1-10 of 1,080) with videos related to
Sort By:
Pageof 108
Oncotargets and Therapy|August 8, 2023
Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future ProspectsYu Saida, Satoshi Watanabe, Toshiaki KikuchiCritical Reviews in Immunology|February 13, 2018
Effect of Lymphodepletion on Donor T Cells and the Role of Recipient Cells Persisting after Cytotoxic Treatments in Cancer ImmunotherapiesSatoshi Watanabe, Masashi Arita, Miho Takahashi, et al.Respiratory Investigation|May 19, 2026
Anti-cancer therapy and the exacerbation of pulmonary nontuberculous mycobacterial infectionTomohiro Tanaka, Naohiro Yanagimura, Masashi Arita, et al.Translational Cancer Research|March 9, 2022
Effectiveness of afatinib in an NSCLC patient with <i>EGFR</i> mutation and early progression to osimertinib: a case reportKoichiro Nozaki, Satoshi Watanabe, Kazuto Nishio, et al.Translational Lung Cancer Research|January 13, 2023
Three non-small cell lung cancer patients who developed pulmonary thromboses during osimertinib treatment and could safely resume concomitant anticoagulation treatment: a report of three casesSatoshi Shoji, Satoshi Watanabe, Yusuke Hanazawa, et al.Translational Lung Cancer Research|November 14, 2025
Investigation of non-completion factors for durvalumab maintenance therapy in locally advanced non-small cell lung cancerMasaaki Kotake, Yuki Sakai, Satoshi Watanabe, et al.Thoracic Cancer|June 19, 2026
Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective StudyMasaaki Kotake, Satoshi Watanabe, Yuki Sakai, et al.Lung Cancer (Amsterdam, Netherlands)|March 21, 2025
The diagnostic value of comprehensive next-generation sequencing for genetic mutations in suspected lung cancer cases with negative pathological cytologyYuka Goto, Satoshi Watanabe, Naohiro Yanagimura, et al.Academic Radiology|September 3, 2024
<sup>18</sup>F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint InhibitorsMotohiko Yamazaki, Satoshi Watanabe, Masaki Tominaga, et al.Translational Lung Cancer Research|March 4, 2022
Prognostic significance of procalcitonin in small cell lung cancerKosuke Ichikawa, Satoshi Watanabe, Satoru Miura, et al.Pageof 108